TABLE 1.
Complex | Binding mode | Molecule length at 40 pN | WLC contour length | WLC persistence length | Overstretching transition |
---|---|---|---|---|---|
Free dsDNA | – | 16.4 μm | 16.0 μm | 40.0 nm | 62–65 pN at 18–27 μm |
Distamycin-A | Minor groove | 16.7 μm | 16.3 μm | 26.7 nm | 70–85 pN at 18–27 μm |
α-Helical peptide | Major groove | 17.1 μm | 16.5 μm | 29.4 nm | 80–85 pN at 22–27 μm; crossover at 17–22 μm |
Ethidium bromide | Intercalating | 22.5 μm | 20.4 μm | 20.7 nm | No transition |
YO-1 | Intercalating | 23.2 μm | 19.8 μm | 29.2 nm | No transition |
Daunomycin | Intercalating | 20.9 μm | 19.8 μm | 28.1 nm | No transition |
YOYO-1 | Bisintercalating | 23.5 μm | 21.8 μm | 11.8 nm | No transition |
Molecular parameters extracted from worm-like-chain model fit of experimental data of free double-stranded λ-DNA and dsDNA complexed with distamycin-A, α-helical peptide Ac-(Leu-Ala-Arg-Leu)3-NH-linker, ethidium bromide, YO-1, daunomycin, and YOYO-1. The concentration of each binding ligand was set to 1 μM, respectively.